TAYLOR STONE: Open Payments
NPI 1750788105 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,263 in 112 payments from 21 companies in 2025. Trend: 2023 $1,559 · 2024 $1,895 · 2025 $2,263
Food & beverage: $2,030Education: $233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $419 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $247 |
| Galderma Laboratories, L.P. | 8 | $190 |
| GENZYME CORPORATION | 5 | $184 |
| Janssen Biotech, Inc. | 14 | $176 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| Incyte Corporation | 7 | $153 |
| LEO Pharma Inc. | 4 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Botanix SB Inc | 5 | $91 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, OPZELURA, ILUMYA, COSENTYX, SOFDRA.
Industry payments across GA — which companies pay providers there.
